Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Finance
Triglide maker reports increased revenues in third quarter, provides updated 2005 and 2006 guidance
November 24th, 2005
First Horizon Pharmaceutical Corp. (FHRX), a specialty-pharmaceutical company, announced increased net revenues in third quarter. Net revenues for the third quarter of 2005 were $58.7 million compared with $41.6 million for the quarter ended September 30, 2004. Net income for the quarter ended September 30, 2005 was $10.6 million, or $0.26 per diluted share, compared with net income of $7.4 million, or $0.18 per diluted share for the third quarter of 2004. Cost of revenues was $8.8 million for the third quarter of 2005, producing gross margins of 85%, compared with gross margins of 79% for the third quarter of 2004. Selling, general, and...
Source: Women's Health Weekly (2005-11-24)
|
